These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 15226270)

  • 1. The cytoplasmic 'linker region' in Toll-like receptor 3 controls receptor localization and signaling.
    Funami K; Matsumoto M; Oshiumi H; Akazawa T; Yamamoto A; Seya T
    Int Immunol; 2004 Aug; 16(8):1143-54. PubMed ID: 15226270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TICAM-1, an adaptor molecule that participates in Toll-like receptor 3-mediated interferon-beta induction.
    Oshiumi H; Matsumoto M; Funami K; Akazawa T; Seya T
    Nat Immunol; 2003 Feb; 4(2):161-7. PubMed ID: 12539043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TICAM-1 and TICAM-2: toll-like receptor adapters that participate in induction of type 1 interferons.
    Seya T; Oshiumi H; Sasai M; Akazawa T; Matsumoto M
    Int J Biochem Cell Biol; 2005 Mar; 37(3):524-9. PubMed ID: 15618008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct binding of TRAF2 and TRAF6 to TICAM-1/TRIF adaptor participates in activation of the Toll-like receptor 3/4 pathway.
    Sasai M; Tatematsu M; Oshiumi H; Funami K; Matsumoto M; Hatakeyama S; Seya T
    Mol Immunol; 2010 Mar; 47(6):1283-91. PubMed ID: 20047764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional evolution of the TICAM-1 pathway for extrinsic RNA sensing.
    Seya T; Matsumoto M; Ebihara T; Oshiumi H
    Immunol Rev; 2009 Jan; 227(1):44-53. PubMed ID: 19120474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcriptional regulation of the human TRIF (TIR domain-containing adaptor protein inducing interferon beta) gene.
    Hardy MP; McGGettrick AF; O'Neill LA
    Biochem J; 2004 May; 380(Pt 1):83-93. PubMed ID: 14960149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-terminal LRRs of human Toll-like receptor 3 control receptor dimerization and signal transmission.
    Takada E; Okahira S; Sasai M; Funami K; Seya T; Matsumoto M
    Mol Immunol; 2007 Jul; 44(15):3633-40. PubMed ID: 17521732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment of a monoclonal antibody against human Toll-like receptor 3 that blocks double-stranded RNA-mediated signaling.
    Matsumoto M; Kikkawa S; Kohase M; Miyake K; Seya T
    Biochem Biophys Res Commun; 2002 May; 293(5):1364-9. PubMed ID: 12054664
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TLR3 signaling in a hepatoma cell line is skewed towards apoptosis.
    Khvalevsky E; Rivkin L; Rachmilewitz J; Galun E; Giladi H
    J Cell Biochem; 2007 Apr; 100(5):1301-12. PubMed ID: 17243100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oligomerized TICAM-1 (TRIF) in the cytoplasm recruits nuclear BS69 to enhance NF-kappaB activation and type I IFN induction.
    Takaki H; Oshiumi H; Sasai M; Kawanishi T; Matsumoto M; Seya T
    Eur J Immunol; 2009 Dec; 39(12):3469-76. PubMed ID: 19795416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TNF receptor-associated factor-1 (TRAF1) negatively regulates Toll/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF)-mediated signaling.
    Su X; Li S; Meng M; Qian W; Xie W; Chen D; Zhai Z; Shu HB
    Eur J Immunol; 2006 Jan; 36(1):199-206. PubMed ID: 16323247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution and integration of innate immune recognition systems: the Toll-like receptors.
    Takeda K
    J Endotoxin Res; 2005; 11(1):51-5. PubMed ID: 15826379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Various members of the Toll-like receptor family contribute to the innate immune response of human epidermal keratinocytes.
    Köllisch G; Kalali BN; Voelcker V; Wallich R; Behrendt H; Ring J; Bauer S; Jakob T; Mempel M; Ollert M
    Immunology; 2005 Apr; 114(4):531-41. PubMed ID: 15804290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual topology of functional Toll-like receptor 3 expression in human hepatocellular carcinoma: differential signaling mechanisms of TLR3-induced NF-kappaB activation and apoptosis.
    Yoneda K; Sugimoto K; Shiraki K; Tanaka J; Beppu T; Fuke H; Yamamoto N; Masuya M; Horie R; Uchida K; Takei Y
    Int J Oncol; 2008 Nov; 33(5):929-36. PubMed ID: 18949355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The expanding family of MyD88-like adaptors in Toll-like receptor signal transduction.
    McGettrick AF; O'Neill LA
    Mol Immunol; 2004 Jul; 41(6-7):577-82. PubMed ID: 15219996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple signaling pathways contribute to synergistic TLR ligand-dependent cytokine gene expression in human monocyte-derived macrophages and dendritic cells.
    Mäkelä SM; Strengell M; Pietilä TE; Osterlund P; Julkunen I
    J Leukoc Biol; 2009 Apr; 85(4):664-72. PubMed ID: 19164128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Subcellular localization of Toll-like receptor 3 in human dendritic cells.
    Matsumoto M; Funami K; Tanabe M; Oshiumi H; Shingai M; Seto Y; Yamamoto A; Seya T
    J Immunol; 2003 Sep; 171(6):3154-62. PubMed ID: 12960343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional signaling by double-stranded RNA: role of TLR3.
    Sen GC; Sarkar SN
    Cytokine Growth Factor Rev; 2005 Feb; 16(1):1-14. PubMed ID: 15733829
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The human adaptor SARM negatively regulates adaptor protein TRIF-dependent Toll-like receptor signaling.
    Carty M; Goodbody R; Schröder M; Stack J; Moynagh PN; Bowie AG
    Nat Immunol; 2006 Oct; 7(10):1074-81. PubMed ID: 16964262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TIR-containing adapter molecule (TICAM)-2, a bridging adapter recruiting to toll-like receptor 4 TICAM-1 that induces interferon-beta.
    Oshiumi H; Sasai M; Shida K; Fujita T; Matsumoto M; Seya T
    J Biol Chem; 2003 Dec; 278(50):49751-62. PubMed ID: 14519765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.